Galaxy Medicare Ltd

Galaxy Medicare Dividend

Galaxy Medicare Limited has fixed September 11, 2026, as the record date for determining shareholder entitlement to the final dividend for the 2025-26 financial year.

Galaxy Medicare Other Announcement

Galaxy Medicare Limited announced the re-appointment of Mr. Purnendu Bhusan Mohanty as Internal Auditor. The appointment is for a term of 12 months.

Galaxy Medicare Annual General Meeting

Galaxy Medicare approved the FY 2025-26 Annual Report and the notice for its 34th AGM, scheduled for September 28, 2026.

Galaxy Medicare Results Correction

Galaxy Medicare Limited submitted a Working Capital Certificate and corrected a clerical error regarding paid-up equity share capital in its XBRL filing.

Galaxy Medicare Other Announcement

Galaxy Medicare Limited filed a compliance report. The company stated that corporate governance reporting requirements for SME platforms are not applicable.

Galaxy Medicare Dividend

Galaxy Medicare Limited recommended a final dividend of ₹0.35 per equity share. The record date and general meeting for shareholder approval will be announced separately.

Galaxy Medicare Management Change

Galaxy Medicare Limited re-appointed Saroj Ray & Associates as Secretarial Auditor for a twelve-month term. The decision ensures continued regulatory compliance and governance oversight.

Execution

12 months

Galaxy Medicare Board Meeting Outcome

Galaxy Medicare Limited approved FY2026 audited results and recommended a Rs.0.35 dividend per share. The board also re-appointed the Managing Director and Whole Time Director.

Value

₹0.35 Cr

Galaxy Medicare Board Meeting Outcome

Galaxy Medicare approved the re-appointment of Dillip Kumar Das as Managing Director and Subhasish Das as Whole Time Director. These leadership extensions ensure management continuity.

Galaxy Medicare H2 FY26 Results: Net Profit ₹1.4 Cr, Down 17.6% YoY

Galaxy Medicare Ltd reported revenue from operations of ₹21.3 Cr (-3.2% YoY) and net profit of ₹1.4 Cr (-17.6% YoY) for H2 FY26.

Key figure

Net profit ₹1.4 Cr · -17.6% YoY

Galaxy Medicare Financial Results

Galaxy Medicare reported audited full-year FY26 revenue of ₹40.00 Crore and a ₹3.42 Crore net profit. The board also recommended a ₹0.35 per share dividend.

Value

₹40.00 Cr

Galaxy Medicare Board Meeting Date

Galaxy Medicare Limited scheduled a board meeting for May 29, 2026. Directors will consider annual audited results and a final dividend declaration.

Galaxy Medicare Other Announcement

Galaxy Medicare Limited informed the National Stock Exchange that Corporate Governance Report requirements under Regulation 27(2) of SEBI LODR are not applicable to the company. As an SME-listed entity, it is exempt from these provisions for the quarter ended March 31, 2026.

Galaxy Medicare Other Announcement

Galaxy Medicare Limited submitted its Structured Digital Database (SDD) Compliance Certificate for the financial year ended March 31, 2026. The certificate, issued by Saroj Ray & Associates, confirms the company maintains a non-tamperable database of UPSI with internal audit trails. No non-compliance was observed during the period.

Galaxy Medicare Other Announcement

Galaxy Medicare Limited submitted its quarterly compliance certificate under SEBI (Depositories and Participants) Regulations for the period ended March 31, 2026. The certificate confirms the processing and dematerialisation of securities by its RTA, Cameo Corporate Services Limited. This is a routine regulatory disclosure with no direct financial impact.